Cidel Asset Management Inc Astrazeneca PLC Transaction History

Cidel Asset Management Inc

  • $1.27 Billion
  • Q3 2024

A detailed history of Cidel Asset Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Cidel Asset Management Inc holds 660,846 shares of AZN stock, worth $43.9 Million. This represents 4.06% of its overall portfolio holdings.

Number of Shares
660,846
Previous 660,427 0.06%
Holding current value
$43.9 Million
Previous $51.5 Million 0.03%
% of portfolio
4.06%
Previous 0.72%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
BUY
$76.67 - $87.62 $32,124 - $36,712
419 Added 0.06%
660,846 $51.5 Million
Q2 2024

Jul 19, 2024
BUY
$66.81 - $80.83 $621,733 - $752,203
9,306 Added 1.43%
660,427 $51.5 Million
Q1 2024

May 08, 2024
BUY
$61.03 - $69.57 $5.61 Million - $6.39 Million
91,862 Added 16.43%
651,121 $44.1 Million
Q4 2023

Feb 12, 2024
BUY
$61.89 - $69.28 $349,183 - $390,877
5,642 Added 1.02%
559,259 $37.7 Million
Q3 2023

Nov 07, 2023
BUY
$64.85 - $71.7 $49,480 - $54,707
763 Added 0.14%
553,617 $37.5 Million
Q2 2023

Aug 11, 2023
SELL
$69.91 - $75.81 $183,304 - $198,773
-2,622 Reduced 0.47%
552,854 $39.6 Million
Q1 2023

May 04, 2023
SELL
$63.15 - $71.6 $722,120 - $818,745
-11,435 Reduced 2.02%
555,476 $38.6 Million
Q4 2022

Feb 06, 2023
SELL
$54.21 - $70.44 $205,998 - $267,672
-3,800 Reduced 0.67%
566,911 $38.4 Million
Q3 2022

Nov 03, 2022
SELL
$53.02 - $135.75 $1.05 Million - $2.69 Million
-19,810 Reduced 3.35%
570,711 $31.3 Million
Q2 2022

Aug 10, 2022
BUY
$59.26 - $71.14 $2.33 Million - $2.8 Million
39,341 Added 7.14%
590,521 $39 Million
Q1 2022

May 10, 2022
SELL
$55.72 - $67.12 $2.14 Million - $2.58 Million
-38,473 Reduced 6.52%
551,180 $36.6 Million
Q4 2021

Feb 08, 2022
SELL
$54.02 - $63.83 $2.67 Million - $3.15 Million
-49,401 Reduced 7.73%
589,653 $34.3 Million
Q3 2021

Nov 05, 2021
SELL
$55.56 - $60.79 $2.06 Million - $2.26 Million
-37,149 Reduced 5.49%
639,054 $38.4 Million
Q2 2021

Aug 10, 2021
BUY
$48.42 - $60.18 $673,086 - $836,562
13,901 Added 2.1%
676,203 $40.5 Million
Q1 2021

May 12, 2021
BUY
$47.16 - $54.44 $14.9 Million - $17.2 Million
316,072 Added 91.29%
662,302 $32.9 Million
Q4 2020

Feb 16, 2021
SELL
$48.52 - $58.02 $9 Million - $10.8 Million
-185,513 Reduced 34.89%
346,230 $17.3 Million
Q3 2020

Nov 09, 2020
BUY
$53.07 - $61.1 $155,282 - $178,778
2,926 Added 0.55%
531,743 $29.2 Million
Q2 2020

Aug 12, 2020
SELL
$43.1 - $55.31 $9.49 Million - $12.2 Million
-220,231 Reduced 29.4%
528,817 $28 Million
Q1 2020

May 12, 2020
SELL
$37.79 - $51.33 $615,145 - $835,549
-16,278 Reduced 2.13%
749,048 $33.5 Million
Q4 2019

Feb 18, 2020
BUY
$42.46 - $50.46 $14.4 Million - $17.1 Million
339,780 Added 79.85%
765,326 $38.2 Million
Q4 2019

Feb 14, 2020
SELL
$42.46 - $50.46 $14.8 Million - $17.6 Million
-348,973 Reduced 45.06%
425,546 $21.2 Million
Q3 2019

Nov 12, 2019
BUY
$40.12 - $45.47 $85,134 - $96,487
2,122 Added 0.27%
774,519 $34.5 Million
Q2 2019

Aug 12, 2019
BUY
$37.28 - $41.68 $22 Million - $24.6 Million
590,876 Added 325.51%
772,397 $31.9 Million
Q2 2019

Aug 08, 2019
SELL
$37.28 - $41.68 $21 Million - $23.5 Million
-563,070 Reduced 75.62%
181,521 $31.9 Million
Q1 2019

May 06, 2019
BUY
$35.49 - $43.02 $1.41 Million - $1.71 Million
39,760 Added 5.64%
744,591 $30.1 Million
Q4 2018

Feb 08, 2019
BUY
$36.86 - $41.49 $3.78 Million - $4.26 Million
102,561 Added 17.03%
704,831 $26.8 Million
Q3 2018

Nov 07, 2018
SELL
$34.76 - $39.72 $2.47 Million - $2.82 Million
-71,081 Reduced 10.56%
602,270 $23.9 Million
Q2 2018

Aug 13, 2018
BUY
$34.55 - $37.05 $23.3 Million - $24.9 Million
673,351 New
673,351 $23.6 Million

Others Institutions Holding AZN

# of Institutions
1,360
Shares Held
476M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Cidel Asset Management Inc Portfolio

Follow Cidel Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cidel Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cidel Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email